News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Camber Capital Management LP
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/24/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/02/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 12/12/2022 |
SC 13G
| Camber Capital Management LP reports a 7.3% stake in Solid Biosciences Inc. |
| 08/19/2022 |
SC 13G
| Camber Capital Management LP reports a 8.1% stake in Quanterix Corporation |
| 05/12/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 03/21/2022 |
SC 13G
| Camber Capital Management LP reports a 7.7% stake in ZIMVIE INC. |
| 07/29/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 11/30/2020 |
SC 13G
| Camber Capital Management LP reports a 7.6% stake in AVROBIO, INC. |
| 07/13/2020 |
SC 13G
| Camber Capital Management LLC reports a 5.5% stake in Change Healthcare Inc |
| 06/29/2020 |
SC 13G
| Camber Capital Management LLC reports a 6.1% stake in Puma Biotechnology, Inc |
| 06/22/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/21/2020 |
SC 13G
| Camber Capital Management LLC reports a 6% stake in Collegium Pharmaceutical, Inc |
| 10/15/2019 |
SC 13G
| Camber Capital Management LLC reports a 12.9% stake in AMAG Pharmaceuticals, Inc. |
| 08/15/2019 |
SC 13G
| Camber Capital Management LLC reports a 8.1% stake in GlycoMimetics, Inc |
| 07/29/2019 |
SC 13G
| Camber Capital Management LLC reports a 5.6% stake in Atara Biotherapeutics, Inc |
| 06/17/2019 |
SC 13G
| Camber Capital Management LLC reports a 5.7% stake in Cyclerion Therapeutics, Inc |
| 03/18/2019 |
SC 13G
| Camber Capital Management LLC reports a 5.9% stake in Brookdale Senior Living Inc. |
| 12/17/2018 |
SC 13G
| Camber Capital Management LLC reports a 6.1% stake in Synthorx, Inc. |
| 11/14/2018 |
SC 13G
| Camber Capital Management LLC reports a 6.8% stake in ZYMEWORKS INC. |
| 10/25/2018 |
SC 13G
| Camber Capital Management LLC reports a 6.6% stake in Clovis Oncology, Inc. |
| 08/13/2018 |
SC 13G
| Camber Capital Management LLC reports a 6.4% stake in Tesaro, Inc. |
| 01/05/2018 |
SC 13G
| Camber Capital Management LLC reports a 6.6% stake in Atara Biotherapeutics, Inc. |
| 08/21/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 07/31/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 05/15/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 01/23/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 11/28/2016 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 11/07/2016 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 09/29/2016 |
SC 13G
| Camber Capital Management LLC reports a 5.8% stake in   PTC Therapeutics, Inc. |
| 02/05/2016 |
SC 13G
| Camber Capital Management LLC reports a 6.9% stake in LDR Holding Corporation |
| 10/23/2013 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 10/01/2013 |
SC 13G
| Camber Capital Management LLC reports a 7.3% stake in Biolase, Inc. |
| 05/09/2013 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 05/29/2012 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
|
|
|